{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:27:40Z","timestamp":1791239260780,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12072-021-10163-0","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T12:34:48Z","timestamp":1618576488000},"page":"437-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-1219","authenticated-orcid":false,"given":"Naruhiro","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Arao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahumi","family":"Takatsuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Setsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroteru","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"10163_CR1","doi-asserted-by":"publisher","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep. 2016;6:25906.","journal-title":"Sci Rep"},{"issue":"144","key":"10163_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"2013","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;2013(144):560\u20139.","journal-title":"Gastroenterology"},{"issue":"147","key":"10163_CR3","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"2014","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Invernizzi P, Mason AL, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology. 2014;2014(147):1338\u201349.","journal-title":"Gastroenterology"},{"issue":"65","key":"10163_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"2016","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR, Pares A, Floreani A, Janssen HL, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;2016(65):321\u20139.","journal-title":"Gut"},{"issue":"50","key":"10163_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"2009","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;2009(50):291\u2013308.","journal-title":"Hepatology"},{"issue":"51","key":"10163_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"2009","author":"European Association for the Study of Liver","year":"2009","unstructured":"European Association for the Study of Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;2009(51):237\u201367.","journal-title":"J Hepatol"},{"key":"10163_CR7","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"PC ter Borg","year":"2006","unstructured":"ter Borg PC, Schalm SW, Hansen BE, van Buuren HR, Dutch PBC Study Group. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol. 2006;101:2044\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"101","key":"10163_CR8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","volume":"2006","author":"J Shi","year":"2006","unstructured":"Shi J, Wu C, Lin Y, et al. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;2006(101):1529\u201338.","journal-title":"Am J Gastroenterol"},{"issue":"122","key":"10163_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/gast.2002.31880","volume":"2002","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Carrat F, Poupon R. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology. 2002;2002(122):652\u20138.","journal-title":"Gastroenterology"},{"key":"10163_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u201343.","journal-title":"N Engl J Med"},{"issue":"38","key":"10163_CR11","first-page":"557","volume":"2008","author":"I Shinji","year":"2008","unstructured":"Shinji I, Hiromasa O, Shuhei N, Zeniya M, Kaneko S, Onji M, et al. The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study. Hepatol Res. 2008;2008(38):557\u201364.","journal-title":"Hepatol Res"},{"issue":"70","key":"10163_CR12","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/hep.30552","volume":"2019","author":"A Honda","year":"2019","unstructured":"Honda A, Tanaka A, Kaneko T, Komori A, Abe M, Inao M, et al. Bezafibrate improves GLOBE and UK-PBC score and long-term outcomes in patients with PBC. Hepatology. 2019;2019(70):2035\u201346.","journal-title":"Hepatology"},{"issue":"130","key":"10163_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"2006","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;2006(130):715\u201320.","journal-title":"Gastroenterology"},{"issue":"136","key":"10163_CR14","first-page":"1281","volume":"2009","author":"M Edith","year":"2009","unstructured":"Edith M, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJM, Haagsma EB, et al. Improved prognosis of patient with PBC that have a biochemical response to UDCA. Gastroenterology. 2009;2009(136):1281\u20137.","journal-title":"Gastroenterology"},{"issue":"48","key":"10163_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"2008","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;2008(48):871\u20137.","journal-title":"Hepatology"},{"issue":"19","key":"10163_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","volume":"1999","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999;1999(19):115\u201321.","journal-title":"Liver"},{"issue":"44","key":"10163_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00535-009-0051-9","volume":"2009","author":"N Azemoto","year":"2009","unstructured":"Azemoto N, Abe M, Murata Y, Hiasa Y, Hamada M, Matsuura B, et al. Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. J Gastroenterol. 2009;2009(44):630\u20134.","journal-title":"J Gastroenterol"},{"issue":"149","key":"10163_CR18","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"2015","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, Nevens F, Lindor KD, Janssen HL, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;2015(149):1804\u201312.","journal-title":"Gastroenterology"},{"issue":"63","key":"10163_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.28017","volume":"2016","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, et al. The UKPBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis. Hepatology. 2016;2016(63):930\u201350.","journal-title":"Hepatology"},{"key":"10163_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13586.2020Oct30","author":"M Takamura","year":"2020","unstructured":"Takamura M, Matsuda Y, Kimura N, Takatsuna M, Setsu T, Tsuchiya A, et al. Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016. Hepatol Res. 2020. https:\/\/doi.org\/10.1111\/hepr.13586.2020Oct30.","journal-title":"Hepatol Res"},{"issue":"43","key":"10163_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"2006","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;2006(43):1317\u201325.","journal-title":"Hepatology"},{"issue":"38","key":"10163_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"2003","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;2003(38):518\u201326.","journal-title":"Hepatology"},{"issue":"6","key":"10163_CR23","first-page":"489","volume":"2001","author":"WR Kim","year":"2001","unstructured":"Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transplant. 2001;2001(6):489\u201394.","journal-title":"Liver Transplant"},{"issue":"28","key":"10163_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hep.510280106","volume":"1998","author":"WR Kim","year":"1998","unstructured":"Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology. 1998;1998(28):33\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"10163_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"2018","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018;2018(3):626\u201334.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"49","key":"10163_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2559.2006.02537.x","volume":"2006","author":"K Hiramatsu","year":"2006","unstructured":"Hiramatsu K, Aoyama H, Zen Y, et al. Proposal of a new staging and grading system of the liver for primary biliary cirrhosis. Histopathology. 2006;2006(49):466\u201378.","journal-title":"Histopathology"},{"issue":"60","key":"10163_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","volume":"2010","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma Y, Zen Y, Harada K, Aishima S, Kitagawa S, Nakanumaet Y. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010;2010(60):167\u201374.","journal-title":"Pathol Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10163-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T07:12:55Z","timestamp":1621840375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10163-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10163"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10163-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Naruhiro Kimura, Masaaki Takamura, Nobutaka Takeda, Yusuke Watanabe, Yoshihisa Arao, Masahumi Takatsuna, Suguru Takeuchi, Hiroyuki Abe, Toru Setsu, Hiroteru Kamimura, Akira Sakamaki, Kenya Kamimura, Atsunori Tsuchiya, and Shuji Terai declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Institutional Review Board of the University of Niigata reviewed and approved this study (approval No. 2020\u20130273). This work was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}